BRUKER CORP

Key metrics

Financial performance

Over the last 9 fiscal years BRUKER CORP's revenue grew from $1.61B to $3.44B, a compound annual growth rate of 8.8%. Net profit margin compressed from 9.5% to -0.2% over the same period - every figure below comes from the company's audited annual filings.

Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.

Key statistics

Latest filings

Browse the full filing history (1,361 filings)

Recent press releases

• Bruker Reports First Quarter 2026 Financial Results2026-05-06

  **Q1 2026 revenues of $823.4 million, up 2.7% year-over-year (yoy), down 4.4% organically**

• Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast2026-04-24

  To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q1 2026 Earnings Webcast” hyperlink in the “Events & Presentations” section. A slide presentation will be referenced during the webcast and will be posted to the Company’s website shortly before the webcast begins.

• Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 20262026-04-17

  MUNICH--(BUSINESS WIRE)-- At ESCMID Global 2026, the Bruker Microbiology & Infection Diagnostics division ( Bruker Corporation, Nasdaq: BRKR) announces the European launch of **MyGenius PRO®**, a fully automated, sample-to-answer (S2A) molecular diagnostics system based on PCR (Polymerase Chain Reaction) technology. Designed for infectious disease diagnostics, the new S2A system enables higher throughput, continuous loading of samples, consumables, and reagents, and supports random-access operation. Like the successful medium-throughput **BeGenius®** system, which excels at assay and sample matrix flexibility, the new higher-throughput MyGenius PRO® automates the entire workflow - from patient sample to diagnostic result - enhancing laboratory efficiency and supporting higher-throughput volume testing needs.

• Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management2026-04-17

  **_MALDI Biotyper (MBT): Launch of proprietary MBT Easy T Kit for consistent sample transfer to MALDI target plates_**

• Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 20262026-04-17

  **_Bruker Spatial Biology features new GeoMx-to-CellScape and CellScape-to-CosMx cross-platform workflows and first-of-its-kind 208-plex CellScape XR spatial proteomics datasets_**

Similar companies

The largest companies sharing BRUKER CORP's SEC industry classification (laboratory analytical instruments).